L’impact des immunosuppresseurs sur les réservoirs du VIH après transplantation rénale

Caractérisation génotypique des réservoirs viraux qui persistent chez les personnes vivant avec le VIH sous traitement antirétroviral

Effet de la production thymique sur l’homéostasie du réservoir du VIH-1 chez des individus recevant une trithérapie antirétrovirale.

Caractérisation des mécanismes moléculaires et virologiques contribuant à la persistance du VIH-1 chez les individus sous thérapie antirétrovirale

Profil transcriptionnel de lymphocytes T CD4+ infectés par le VIH-1 de manière latente chez des individus sous trithérapie antirétrovirale

Inflammatory phenotype, senescence, and viscoelasticity imaging of macrophages in HIV

Immunovirological determinants of breakthrough COVID-19 disease in vaccinated or previously infected individuals

Single-cell approaches to characterize and target the cellular reservoirs of HIV infection

Closing the Comorbidity Gap for People Living with HIV : a Randomized Controlled Trial of Fostemsavir to Reduce Inflammaging

Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and CD4+ T-cells for HIV cure

COVIH study: COVID-19 burden in HIV infected individuals

Immunosuppressive pathways and HIV reservoirs in tissues

Discovering immune pathways to successful aging in HIV infection

COVID-19 Variant Supplement - Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID-19 disease

Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID-19 disease

IL-32, a new biomarker and potential therapeutic target for chronic inflammation and residual reservoirs in HIV-infected individuals

Interfering with HIV persistence in CD4+ T cells during antiretroviral therapy

DARE: Delaney AIDS Research Enterprise to find a cure HIV

Reducing viral reservoirs by opening HIV-1 Env to antibody attack

Réservoirs du VIH et stratégies d'éradication

The lungs as HIV reservoirs: Interplay between disrupted respiratory immunity and Chronic Obstructive Pulmonary Disease (COPD)

Targeting cytolytic cells to lymphoid sites of HIV persistence

Latent HIV reservoir in early treated Thai children

Locking out HIV from CD4 T cells: A pilot study of the impact of anti a4b7 antibody (vedolizumab) on viral control following analytical treatment interruption

Discovering immune pathways to successful aging in HIV infection

Mesure des réservoirs du VIH en utilisant la méthode Tilda, projets RV 254, RV 397, Rv 412

Stratégies d'éradication des réservoirs du VIH

THE CANADIAN HIV CURE ENTERPRISE (CANCURE)

Resevoir dynamics in patients treated in very early acute HIV infection

Central me mory CD4 T cell infection: key role in ART response and HIV persistence

Reducing Proviral HIV DNA with interferon-a Immunotherapy

Characterization, measurement and eradication of latent VIH reservoirs

Modulating the Impact of Critical Events in early HIV infection: effect of ART initiation and early ART

The size and maintenance of the latent HIV reservoir in T-cell subsets

Purging the latent HIV reservoir at ART: A new eradication strategy

Cell surface marker combinations to identify latently infected CD4 + Cells in vivo

Réseau SIDA/MI - Vieillissement et persistance du VIH sous trithérapie: le rôle du thymus

Purging the latent HIV reservoir at ART: A new eradication strategy

TILDA: a new sensitive and precise assay to measure the size of the latent HIV reservoir

Fonds de recrutement CRCHUM

DARE: Delaney AIDS Research Enterprise to find a cure

Identifying and taargeting HIV persistence in T cell subsets during ART